These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17935663)

  • 1. Current status and future directions in the treatment of multiple myeloma.
    Hou J; Wang M
    Chin Med J (Engl); 2007 Oct; 120(19):1651-4. PubMed ID: 17935663
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous transplantation in multiple myeloma.
    Bladé J
    Haematologica; 2006 Sep; 91(9):1157. PubMed ID: 16956811
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation in multiple myeloma: none, one, or two?
    Harousseau JL
    Curr Hematol Rep; 2003 May; 2(3):171-2. PubMed ID: 12901337
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple myeloma: treatment options for an incurable disease.
    Pandit SR
    J Assoc Physicians India; 2005 Dec; 53():1060-4. PubMed ID: 16572964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autologous stem-cell transplantation in multiple myeloma.
    Attal M; Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of multiple myeloma: a new molecular target therapy].
    Ozaki S; Kosaka M
    Rinsho Ketsueki; 2000 May; 41(5):421-5. PubMed ID: 10879104
    [No Abstract]   [Full Text] [Related]  

  • 8. NCCN practice guidelines for multiple myeloma. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):317-51. PubMed ID: 10028515
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of autologous hematopoietic stem cell transplantation in myeloma.
    Mehta J; Singhal S
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S28-S34. PubMed ID: 18724294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem-cell transplantation for multiple myeloma.
    Louw VJ; Louw H; Webb MJ
    N Engl J Med; 2009 Sep; 361(11):1118-9; author reply 1119. PubMed ID: 19741236
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple myeloma: future directions in autologous transplantation and novel agents.
    Hari PN; McCarthy PL
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S20-5. PubMed ID: 23290439
    [No Abstract]   [Full Text] [Related]  

  • 13. Allografting or autografting for myeloma.
    Moreau P; Harousseau JL; Attal M
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma.
    Braiteh F; Hymes SR; Giralt SA; Jones R
    J Clin Oncol; 2008 Sep; 26(27):4511-3. PubMed ID: 18802165
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptom burden after autologous stem cell transplantation for multiple myeloma.
    Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
    Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and staging in multiple myeloma.
    Fonseca R; San Miguel J
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1115-40, ix. PubMed ID: 17996591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment for multiple myeloma: current status and future strategy in Japan].
    Iida S
    Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling.
    Iacobelli S; Apperley J; Morris C
    Exp Hematol; 2008 Nov; 36(11):1567-71. PubMed ID: 18722040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of stem cell transplantation.
    Harousseau JL
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.